To evaluate the effectiveness of the reaspiration or rebiopsy of pulmonary lesions (second PCNA) in cases where the pathologic results are inconclusive upon initial percutaneous needle aspiration biopsy (PCNA). Materials and Methods: A total of 364 PCNA cases (350 initial PCNA, 14 second PC-NA) were performed under CT or fluoroscopy guidance for all the 350 patients enrolled. The procedure was performed by either using an automated biopsy gun with a 20-G needle (298 cases) or a 20-G aspiration needle (66 cases). The pathologic agreement rates between the initial and second PCNA, as well as the causes for a second PCNA, were evaluated. Finally the type and rate of complication were also evaluated. Results: The second PCNA rate was 4.0% (14/350). The causes for a second PCNA, following the initial PCNA included unexpected pathologic results (n = 7) and inconclusive pathologic results (n = 7). Of the seven cases which had unexpected pathologic results from their initial PCNAs, five had similar pathologic results after a second PC-NA. Also, of the seven cases of inconclusive pathologic results, such as atypical cells, the scanty cellularity or necrosis upon an initial PCNA, six cases revealed a malignancy on a second PCNA. The overall complication rate, including both the initial and second PCNAs was 14.0% (51/364). Conclusion: A second PCNA was performed to help resolve the exact diagnosis for a pulmonary lesion in cases of inconclusive pathologic results upon an initial PCNA.
A percutaneous needle aspiration biopsy (PCNA) of the lung is a well established method used for the cytologic diagnosis of pulmonary lesions (1) . PCNA is generally regarded as a safe procedure with limited morbidity and extremely rare mortality. The diagnostic accuracy has been reported as greater than 80% for benign disease and as greater than 90% for for malignant disease (2) (3) (4) (5) (6) (7) (8) . Automated needle biopsies are presently available and reports have shown the diagnostic accuracy of this technique comparable to aspiration biopsy (3) . Reaspiration or rebiopsy (a second PCNA) cases might occur in cases where the initial pathologic results were inconclusive. Few radiologic reports address the potential increase in diagnostic effectiveness of a second PC-NA in the lung. The purpose of this study was to evaluate the agreement rate of the pathologic results between an initial PCNA and a second PCNA in the lung of cases with inconclusive results.
Materials and Methods
Three hundred and eighty four consecutive percutaneous thoracic biopsies using automated biopsy devices or fine needle aspiration were performed at our institution between July 2004 and December 2006. Of these, 20 were cases of extrapulmonary thoracic lesions such as chest wall (n = 10), mediastinum (n = 5), or pleura (n = 5), and were excluded from this study. Hence, the remaining 364 cases of PCNA were performed on pulmonary parenchymal lesions. Of the 364 cases, 14 included patients having undergone a second PCNA due to unexpected or inconclusive pathologic results from an initial PCNA. All the repeated PCNAs were performed at the same site as the initial PCNA site. Hence, a total of 350 patients [219 male (62.5%) and 131 females (37.5%)], were part of this study. The age range of the study population was 8 88 years (mean, 62.5 years). In addition, the range in lesion diameter was 0.5 13.6 cm (mean 3.4 cm). The lobar location of the lesions was distributed as follows: right upper lobe (n = 111), left upper lobe (n = 88), left lower lobe (n = 79), right lower lobe (n = 69) and right middle lobe (n = 17). All patients underwent a diagnostic chest CT examination prior to a biopsy. All PCNA cases were performed using CT (Hispeed, GE Medical Systems, Milwaukee, WI, U.S.A.) in 251 or fluoroscopy (Integris Allura, Siemens, Erlangen, Germany) in 113 as an imaging guidance. Selection of imaging guidance was based on the ease of accessibility and proper visibility of each lesion on CT or fluoroscopy. A contrast media was not used on CT or fluoroscopy. Prior to each procedure, the risks and benefits of the procedure were communicated to each patient. Moreover, patient consent was obtained in each case. The procedure was performed with patients in the prone, supine, oblique, or lateral decubitus positions. A total of 298 cases were performed using an automated core biopsy gun (Magnum , Bard, Covington, GA, U.S.A.) with a 20-gauge needle; whereas 66 cases used a 20-gauge aspiration needle. Following the procedure, the patients were monitored and also underwent a posteroanterior erect expiratory chest radiograph at two hours after having undergone a PCNA.
The pathologic agreement rate between the initial and second PCNA, as well as the causes of a second PCNA, was evaluated. Moreover, the rate and type of PCNA complication were also evaluated. The data were analyzed via the Chi-square test and Fisher's exact test using the SAS (Statistical Analysis System 9.1 version) software.
Results
Of the 350 patients enrolled for a PCNA, 14 had to undergo a second PCNA (4.0%). The mean diameter of the second PCNA lesions was 4.3 cm (range, 1.5 10.8 cm). The lobar location of the lesions was as follows: five in the right upper lobe, three in the left upper lobe, three in the left lower lobe, two in the right lower lobe and one in the right middle lobe.
Of the 251 cases which underwent an initial PCNA using CT as an imaging guidance, seven cases required a second PCNA. Of 113 cases of initial PCNA using fluoroscopy, seven cases required a second PCNA. Therefore, there was no statistically significant difference between the CT and fluoroscopy methods as far as imaging guidance with respect to a second PCNA (p = 0.1428). Of the 14 total cases requiring a second PCNA, the same image guidance method initially used for the initial PCNA was used in 11 cases for the second PCNA. On the other hand a CT was performed in seven cases, as opposed to four for fluoroscopy. In three of the cases requiring a second PCNA, a different image guidance method was used for the second PCNA (CT) from the initial guidance method (fluoroscopy).
Of 287 cases of initial PCNA using an automated gun as a biopsy tool, a second PCNA was necessary in 11 cases. Moreover, of the 63 cases using needle aspiration as an initial PCNA, a second PCNA was necessary in the three cases. Furthermore, no statistically significant difference between the automated gun biopsy and needle aspiration as a biopsy tool for a second PCNA (p = 0.7266). Nine cases used the same aspiration or biopsy tool for the initial and second PCNA (automated gun using 20-gauge needle: 8 cases; 20-gauge aspiration needle: 1 case). For the other three cases, a 20-gauge aspiration needle was used in the initial PCNA, followed by an automated gun using a 20-gauge needle for the second PC-NA. In the other two cases, an automated gun using 20-gauge needle was used in the initial PCNA, followed by a 20-gauge aspiration needle for the second PCNA.
The causes for a second PCNA included unexpected pathologic results for the clinical or radiologic findings (n = 7) and inconclusive pathologic results (n = 7) for the initial PCNA. The 7 cases with inconclusive pathologic results included cases with atypical cells (n = 2), scanty cellularity (n = 2), necrosis (n = 2) and hemorrhage (n = 1). The two cases of atypical cells indicated non-small cell lung cancer for the initial PCNA, followed by melanoma for the second PCNA. The two cases of scanty cellularity revealed small cell lung cancer for the initial PCNA, followed by adenocarcinoma for the second PCNA. The two cases of necrosis indicated small cell lung cancer for the initial PCNA, followed by a melanoma on the second PCNA. Lastly, the hemorrhagic case on the initial PCNA revealed interstitial fibrosis on the second PCNA. Of the seven cases of unexpected pathologic results for the initial PCNA, five shared the same initial PCNA pathologic results with the results of the second PCNA including inflammation (n = 3), sarcoma (n = 1) and tuberculosis (n = 1). The two cases with pathologic results which were different for the initial and second PCNA included combined cases of pneumonia and tuberculosis, as well as inflammation and metastasis, respectively. In cases of non-tumor lesions on the initial and second PCNA, the final diagnosis of each lesion was supported by the clinical and radiological follow up studies ( Table 1) .
The cumulative complication rate of the initial and second PCNA was 14.0% (51 of 364 cases). A series of complications occurred on the initial PCNA, which primarily included pneumothorax (n = 39), hemoptysis (n = 9), severe pain (n = 2) and lingular atelectasis (n = 1). The two cases of pneumothorax required a chest tube insertion. All cases of hemoptysis were mild and did not require a vascular embolization. Severe pain and lingular atelectasis were overcome without any medical treatment. In the case of CT guided initial or second PCNA, each of the complications include the pneumothorax (n = 25), hemoptysis (n = 5), severe pain (n = 1) and lingular atelectasis (n = 1). Of the cases with fluoroscopy guided initial or second PCNA, the complications comprise pneumothorax (n = 14), hemoptysis (n = 4) and severe pain (n = 1). As for the complication rate of the pneumothorax, no statistically significant difference was found between the CT and fluoroscopy as an imaging guidance (p = 0.4881). were observed in the remaining 13 cases (Table 2) . To date, this study did not reveal a significant difference between the rate of cases requiring further PCNA, depending on the location of the lesions; however, small enough numbers were included in the sample numbers were included (p = 0.9091).
Discussion
Of the seven cases with inconclusive pathologic results including atypical cells, scanty cellularity or necrosis on initial PCNAs, six cases revealed a malignancy on the second PCNA. Hence, a second PCNA might be necessary in cases which indicate atypical cells, scanty cellularity or necrosis on an initial PCNA. Although technical failure is an important factor of PCNA, avoidance of a necrotic or hemorrhagic area during the PCNA of lung lesions is also important and reduces the frequency of requiring further evaluation such as a second PCNA. Of the seven cases with unexpected pathologic results from an initial PCNA, taking into consideration clinical or radiological findings, different pathologic results on second PCNA were obtained in two cases. Although the other five cases, the pathologic results were the same. The final pathologic results for the two cases were tuberculosis and metastasis, hence, a second PCNA might be considered in cases with unexpected pathologic results from initial PCNAs. Although, in the 14 cases in which only PCNA was used as a second biopsy method, other additional testing, including a bronchoscopic biopsy or transbronchial lung biopsy might be considered on a situation-specific basis.
In this study, the mean diameter of the second PCNA cases was larger than that for overall cases. This may be due to large necrotic or hemorrhagic foci of the lesions in some cases. Therefore, exact targeting of the lesions using CT guidance might be helpful in certain cases with a large necrotic or hemorrhagic portion.
The complication rate for the study cases was 14.0% (51/364). The complication results as a function of imaging guidance method, the complication rates of the pneumothorax were 10.0% (25/251) for the CT and 12.4% (14/113) for the fluoroscopy method. Regarding the development of the pneumothorax, no statistically significant difference was demonstrated between the CT and fluoroscopy imaging guidance methods (p = 0.4881). However, pneumothorax still remains the most common complication of the CT-guided lung biopsy (7, 9) . Some reports concluded that smaller needles are safer (10, 11) . We used the same needle diameter for the automated gun core biopsy and the aspiration biopsy, to correctly compare the risk rates, which depend upon the diameter of needle. The complication rates of hemoptysis were 2.0% (5/251) on CT and 3.5% (4/113) on fluoroscopy. With regards to the development of hemoptysis, no statistically significant difference was found between CT and fluoroscopy as an imaging guidance (p = 0.4675). Hence, CT or fluoroscopy might be a helpful imaging guidance to decrease hemoptysis rates in PCNAs of the lung. Moreover, no severe complications were reported for cases requiring a second PCNA case. Although this study has some limitations such as small cases of second PCNA and a retrospective study, The second PCNA has some useful and safe method for conclusive diagnosis of pulmonary lesions in cases of inconclusive or unsatisfactory results from an initial PC-NA. In particular, a second PCNA was more important in cases of atypical cells, scanty cellularity, or necrosis of the pathologic results on initial PCNA.
In conclusion, a second PCNA might be a helpful tool in the diagnosis of pulmonary lesions in cases of unexpected or inconclusive pathologic results on initial PC-NA.
